Table 4 The effect of interventions on serum sodium concentrations
Length of follow-up | p* | p† | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | 15 min | 30 min | 45 min | 60 min | 75 min | 90 min | 105 min | 120 min | |||
Sodium, mmol/L | |||||||||||
Group 1 | 139.9 (139.0–140.8) | 140.1 (139.2–140.9) | 141.5 (140.7–142.4) | 142.5 (141.7–143.4) | 143.0 (142.1–143.9) | 143.2 (142.3–144.1) | 141.5 (138.6–144.5) | 141.0 (140.7–142.4) | 141.0 (140.1–141.9) | 0.55 | 0.16 |
Group 2 | 140.1 (139.6–141.3) | 139.0 (138.1–139.9) | 139.2 (138.3–140.1) | 138.8 (137.9–139.7) | 138.2 (137.3–139.1) | 138.3 (137.4–139.1) | 138.8 (137.9–139.7) | 139.1 (138.2–139.9) | 138.9 (138.0–139.8) | ||
Group 3 | 138.2 (137.3–139.1) | 138.7 (137.9–139.6) | 140.1 (139.2–140.9) | 140.7 (139.9–141.6) | 141.4 (140.5–142.2) | 140.8 (139.9–141.7) | 140.1 (139.2–140.9) | 139.1 (138.2–139.9) | 139.0 (138.1–139.9) | ||
Group 4 | 138.9 (138.0–139.8) | 137.9 (137.0–138.8) | 137.5 (136.7–138.4) | 137.8 (136.9–138.7) | 138.2 (137.3–139.1) | 138.4 (137.5–139.2) | 138.4 (137.5–139.2) | 138.0 (137.1–138.9) | 138.1 (137.2–138.9) | ||
p‡ | 0.71 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |